Thrombocytopaenia Clinical Trial
Official title:
An Open-label, Dose Ranging Study to Assess the Safety, Efficacy, and Pharmacokinetics of an Oral Thrombopoietin Receptor Agonist (Eltrombopag) Administered to Subjects Receiving Adriamycin and Ifosfamide (AI) Regimen
The study will evaluate the safety and tolerability, optimal biologic dose, and pharmacokinetics of eltrombopag for patients with advanced sarcoma who have a low platelet count and are receiving ADRIAMYCIN and ifosfamide (AI) chemotherapy.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT01440374 -
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
|
Phase 2 | |
| Completed |
NCT01957176 -
A Rollover Study to Provide Continued Treatment With Eltrombopag
|
Phase 4 | |
| Withdrawn |
NCT01055600 -
Milk-only Lactation Study for Patients on Eltrombopag
|
Phase 4 | |
| Completed |
NCT01147809 -
Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
|
Phase 2 | |
| Terminated |
NCT02158936 -
A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)
|
Phase 3 | |
| Completed |
NCT00102726 -
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
|
Phase 2 | |
| Completed |
NCT01235988 -
Meta-analysis - Eltrombopag
|
N/A | |
| Completed |
NCT01236014 -
Indirect Comparison Between Eltrombopag & Romiplostim
|
N/A | |
| Completed |
NCT01657552 -
Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects
|
Phase 1 |